🇺🇸 FDA

Intelligence · Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda — grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≤24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months — use filters for patent-cliff planning.

Page 3 of 30

  1. US 12005054

    Piperidinyl-3-(aryloxy)propanamides and propanoates

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11993570

    Cationic lipids

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11987586

    Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11981912

    Adeno associated virus vectors for the treatment of hunter disease

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11975062

    Zika vaccines and immunogenic compositions, and methods of using the same

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11970483

    Heterocyclic compound

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11964008

    Method for inactivating zika virus and for determining the completeness of inactivation

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11957867

    Syringe stabilizer

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11958845

    Heterocyclic compound

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11958850

    Heteroaryl compounds for kinase inhibition

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11957684

    Treatment of heavy menstrual bleeding associated with uterine fibroids

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11952344

    Heterocyclic compound and use thereof

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11938174

    Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11939327

    Heterocyclic compounds

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11931399

    Compositions and methods for dengue virus chimeric constructions in vaccines

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11905285

    Inhibitors of plasma kallikrein and uses thereof

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11897879

    Heterocyclic compound

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11892450

    Evaluation, assays and treatment of pKal-mediated disorders

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11891431

    Removal of serine proteases by treatment with finely divided silicon dioxide

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11884731

    Vedolizumab for the treatment of fistulizing Crohn's disease

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11884945

    Methods for purification of arylsulfatase A

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11857575

    Mesenchymal stem cell-derived exosomes and their uses

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11851481

    Treatment of central nervous system disorders by intranasal administration of immunoglobulin g

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11851449

    Heterocyclic amide compounds having an RORvt inhibitory action

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11834409

    Heterocyclic NMDA antagonists

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11827601

    Heterocyclic NMDA antagonists

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11826415

    Method of conferring a protective immune response to Norovirus

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11815516

    Protein biomarkers for diseases associated with the contact activation system

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11793855

    TFPI inhibitors and methods of use

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11795216

    Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11793812

    Methods of treating endometriosis

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11786608

    Isoquinolinyl triazolone complexes

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11787796

    Plasma Kallikrein inhibitors and uses thereof

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11780904

    Method of producing recombinant high molecular weight vWF in cell culture

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11779635

    Subcutaneous administration of ADAMTS13

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11760803

    Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11746109

    Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11744893

    Constrained conditionally activated binding proteins

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11744892

    Constrained conditionally activated binding proteins

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11749394

    Method and apparatus for providing a pharmacokinetic drug dosing regimen

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11746155

    Cannabinoid receptor type 1 (CB1) binding proteins and uses thereof

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11739152

    Antibodies which bind Fc receptors (FcRn)

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11730802

    Zika vaccines and immunogenic compositions, and methods of using the same

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11725024

    Antibody drug conjugates

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11717565

    Recombinant BCG overexpressing phoP-phoR

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11713311

    Heterocyclic compound

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11707536

    Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11701421

    Compositions and methods for stabilizing flaviviruses with improved formulations

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.